Business Description
Medico Remedies Ltd
ISIN : INE630Y01024
Share Class Description:
NSE:MEDICO: Ordinary SharesTotal Employee Number:
213Compare
Compare
Traded in other countries / regions
540937.India IPO Date
2022-05-26Description
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It operates in single segment single segment of manufacturing medicines including Antihy pertensive Antidiabetics Antibictics Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets, so many drugs used for treatment of so many diseases for oral use as well as external preparations like creams & ointments which includes anti infectives ,antifungals ,antibiotics ,steroidal preparations etc. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 0.84 | |||||
Interest Coverage | 7.71 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.79 | |||||
Beneish M-Score | -1.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.2 | |||||
3-Year EBITDA Growth Rate | 12.5 | |||||
3-Year EPS without NRI Growth Rate | 22 | |||||
3-Year FCF Growth Rate | -4.2 | |||||
3-Year Book Growth Rate | 19.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.81 | |||||
9-Day RSI | 47.3 | |||||
14-Day RSI | 44.47 | |||||
3-1 Month Momentum % | 22.61 | |||||
6-1 Month Momentum % | -7.96 | |||||
12-1 Month Momentum % | 12.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.66 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 78.89 | |||||
Days Sales Outstanding | 115.87 | |||||
Days Payable | 110.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.83 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.67 | |||||
Operating Margin % | 6.75 | |||||
Net Margin % | 6.36 | |||||
EBITDA Margin % | 11.13 | |||||
FCF Margin % | 0.67 | |||||
OCF Margin % | 2.85 | |||||
ROE % | 19.21 | |||||
ROA % | 9.58 | |||||
ROIC % | 11.72 | |||||
3-Year ROIIC % | 11.45 | |||||
ROC (Joel Greenblatt) % | 25.13 | |||||
ROCE % | 28.99 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.79 | |||||
PE Ratio without NRI | 25.79 | |||||
Shiller PE Ratio | 57.94 | |||||
Price-to-Owner-Earnings | 46.59 | |||||
PEG Ratio | 1.03 | |||||
PS Ratio | 1.64 | |||||
PB Ratio | 4.51 | |||||
Price-to-Tangible-Book | 4.51 | |||||
Price-to-Free-Cash-Flow | 245.51 | |||||
Price-to-Operating-Cash-Flow | 57.91 | |||||
EV-to-EBIT | 17.9 | |||||
EV-to-EBITDA | 15.49 | |||||
EV-to-Revenue | 1.72 | |||||
EV-to-FCF | 256.9 | |||||
Price-to-GF-Value | 0.54 | |||||
Price-to-Projected-FCF | 67.51 | |||||
Price-to-DCF (Earnings Based) | 1.09 | |||||
Price-to-DCF (FCF Based) | 26.57 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
Price-to-Graham-Number | 2.27 | |||||
| Price-to-Net-Current-Asset-Value | 6.67 | |||||
Earnings Yield (Greenblatt) % | 5.59 | |||||
FCF Yield % | 0.41 | |||||
Forward Rate of Return (Yacktman) % | 18.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medico Remedies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2,063.773 | ||
| EPS (TTM) (₹) | 1.59 | ||
| Beta | 0.9454 | ||
| 3-Year Sharpe Ratio | -0.23 | ||
| 3-Year Sortino Ratio | -0.3 | ||
| Volatility % | 57.19 | ||
| 14-Day RSI | 44.47 | ||
| 14-Day ATR (₹) | 1.95313 | ||
| 20-Day SMA (₹) | 41.711 | ||
| 12-1 Month Momentum % | 12.36 | ||
| 52-Week Range (₹) | 30.22 - 56.88 | ||
| Shares Outstanding (Mil) | 82.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medico Remedies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medico Remedies Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 5:1 Stock Split | 2023-03-16 | 73.03 (-1.58%) |
Show
Entries
Medico Remedies Ltd Frequently Asked Questions
What is Medico Remedies Ltd(NSE:MEDICO)'s stock price today?
The current price of NSE:MEDICO is ₹41.18. The 52 week high of NSE:MEDICO is ₹56.88 and 52 week low is ₹30.22.
When is next earnings date of Medico Remedies Ltd(NSE:MEDICO)?
The next earnings date of Medico Remedies Ltd(NSE:MEDICO) is .
Does Medico Remedies Ltd(NSE:MEDICO) pay dividends? If so, how much?
Medico Remedies Ltd(NSE:MEDICO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medico Remedies Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers